ClinicalTrials.gg

Periodontitis clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 1,235 studies for Periodontitis across more than 10 countries. 298 are recruiting or about to start. 816 of them are mainly about Periodontitis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-16. Counting its 4 narrower conditions too, such as Chronic Periodontitis: 1,911 studies, 407 open.

ClinicalTrials.gov finds 2,149 studies for Periodontitis. How that becomes 1,229 here

This page counts the studies the registry files under Periodontitis, and those it files under no condition that list Periodontitisthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 2,149Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −675Filed under a narrower condition, counted on its own pageChronic Periodontitis 276 · Periapical Periodontitis 238 · Periodontal Pocket 61 · Aggressive Periodontitis 36
  3. −40List Periodontitis as a condition, but the registry did not file them under itMost often written as “Chronic Apical Periodontitis” (8), “Asymptomatic Apical Periodontitis” (7), and “Symptomatic Apical Periodontitis” (5). The registry filed them under other conditions only, most often Pain, Postoperative (22) and Dental Pulp Necrosis (5).
  4. −205Match it another way180 name it in the title, 6 in a keyword, and 19 by a synonym or other text the search reads.
  5. 1,229The count on this page12 of them list Periodontitis in their own words; the registry filed them under no condition.

Status

Completed
713
Recruiting
160
Status unknown
148
Not yet recruiting
117
Active, not recruiting
58
Enrolling by invitation
21

Phase

Phase 2
72
Phase 4
65
Phase 3
44
Phase 1
34
Early Phase 1
26

Where

Turkey
261
Egypt
119
Italy
85
United States
75
India
70
Brazil
48

Who develops what

Add Periodontitis to watchlistPro · free during the betaEvery Monday by email · turn it off any time

Every program with a company-led study here in the last two years, whatever its size: 2 programs from 2 companies, 1 with this as their studies’ main aim; 1 with a live phase 3 study; 0 primary completions in the next 12 months. Compare Colgate Palmolive and Longbio Pharma (Suzhou) here →

Comparator & background therapies

What other companies’ phase 2+ studies give as the comparator or the background here (its leading trial sponsor and partners left out): a sign of what new drugs are measured against, not by itself the standard of care, its prescriptions or its market.

None given by two companies or more yet.

Programs

“Meets, by arms” reads each study’s arms: vs its arm against the therapy’s; + X vs a combination against it; added to it plus the therapy against the therapy; studied with given together only. The next primary completion is the next phase-3 study’s when there is one.

The 2 programs — sign in to see the whole list, free: filter by phase and aim, sort by late development, direct comparisons or the next primary completion.

Primary completion in the next 12 months (0)

Live phase 2 and 3 studies of these programs. Primary completion is when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced.

None in the next 12 months.

Read from ClinicalTrials.gov, industry-led studies. Main aim: this is the study’s judged main condition; named, not the main aim: the sponsor names it, the study is about something else; registry mapping only: only the registry’s mapping put it here. Leading trial sponsor is the company leading the most industry studies of a drug, a measure of trial activity, not of rights. US and EU rights, and Approved: from the regulators’ records (FDA’s Drugs@FDA via openFDA; EMA’s medicines data) — the holder of a marketed or authorized original, generics and other companies’ versions; not rights elsewhere, nor approval for this condition. Phase 4 trial recorded, where neither lists it: a phase 4 study exists somewhere. Not read yet: labels by indication, exclusivity, licenses, line of therapy, academic comparators, sales.

What is being tested here

Drugs under test in Periodontitis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug classes tested here NSAIDs 1 open

Coming up

89studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 160 Periodontitis studies recruiting now, 79 (49%) set no upper age limit and 60 (38%) stop at 75 or younger. 12 (8%) take children under 18. 2 (1%) are for women only and 0 (0%) for men only; 77 (48%) take healthy volunteers.

Recruiting studies that take each age, of 160
AgeWomenMen
108 (5%)7 (4%)
18126 (79%)124 (78%)
30153 (96%)151 (94%)
40157 (98%)155 (97%)
50151 (94%)150 (94%)
65139 (87%)138 (86%)
75103 (64%)102 (64%)
8585 (53%)84 (53%)

Across all 1,235 studies, recruiting or not: 57% stop at 75 or younger and 43% at 65; 9% take children; 4% are for women only and 1% for men only; 52% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Periodontitis studies take

Of 30 phase 4 interventional studies under Periodontitis, half reached primary completion within 11 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 112 mo6–19 · 27 studies——
Phase 215 mo8–21 · 18 studies——
Phase 411 mo7–22 · 30 studies—17 mo7–22 · 29 studies
Interventional, no phase16 mo8–31 · 496 studies—15 mo8–31 · 482 studies
Observational13 mo7–30 · 86 studies—17 mo7–30 · 85 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 18, 2026.

Newly registered20

Show 15 more

Studies

Recruiting first, then most recently updated. Showing 50 of 1,235. Browse all 1,235 → or search them.